LMR Partners’s Contineum Therapeutics CTNM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$209K Buy
+15,600
New +$232K ﹤0.01% 1386

Other funds holding CTNM

LMR Partners's CTNM Position: Q3 2026 in Review

LMR Partners opened a new position in Contineum Therapeutics (CTNM) in Q3 2026: 15,600 shares worth $209K. The stake represents ﹤0.01% of the portfolio and ranks #1386 among its holdings.

118 funds tracked by Wall St. Rank hold CTNM as of Q3 2026.

  • LMR Partners held 15,600 shares of Contineum Therapeutics worth $209K as of Q3 2026.
  • Contineum Therapeutics was a new LMR Partners position in Q3 2026.
  • Contineum Therapeutics made up ﹤0.01% of LMR Partners's portfolio in Q3 2026, its #1386 holding.
  • 118 funds tracked by Wall St. Rank held Contineum Therapeutics as of Q3 2026.

Based on LMR Partners's 13F filing for Q3 2026, filed 16 Nov 2026.